Bioventus, Inc. (BVS)
9.95
-0.67
(-6.31%)
USD |
NASDAQ |
Nov 19, 16:00
9.96
+0.01
(+0.10%)
After-Hours: 20:00
Bioventus Enterprise Value : 945.94M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 945.94M |
| November 18, 2026 | 991.80M |
| November 17, 2026 | 990.44M |
| November 16, 2026 | 980.85M |
| November 13, 2026 | 994.54M |
| November 12, 2026 | 1.008B |
| November 11, 2026 | 1.017B |
| November 10, 2026 | 1.030B |
| November 09, 2026 | 1.019B |
| November 06, 2026 | 991.12M |
| November 05, 2026 | 995.91M |
| November 04, 2026 | 1.047B |
| November 03, 2026 | 1.014B |
| November 02, 2026 | 1.165B |
| October 30, 2026 | 1.177B |
| October 29, 2026 | 1.283B |
| October 28, 2026 | 1.268B |
| October 27, 2026 | 1.252B |
| October 26, 2026 | 1.272B |
| October 23, 2026 | 1.289B |
| October 22, 2026 | 1.294B |
| October 21, 2026 | 1.240B |
| October 20, 2026 | 1.220B |
| October 19, 2026 | 1.188B |
| October 16, 2026 | 1.175B |
| Date | Value |
|---|---|
| October 15, 2026 | 1.210B |
| October 14, 2026 | 1.189B |
| October 13, 2026 | 1.193B |
| October 12, 2026 | 1.191B |
| October 09, 2026 | 1.159B |
| October 08, 2026 | 1.134B |
| October 07, 2026 | 1.139B |
| October 06, 2026 | 1.162B |
| October 05, 2026 | 1.190B |
| October 02, 2026 | 1.164B |
| October 01, 2026 | 1.186B |
| September 30, 2026 | 1.198B |
| September 29, 2026 | 1.238B |
| September 28, 2026 | 1.240B |
| September 25, 2026 | 1.225B |
| September 24, 2026 | 1.206B |
| September 23, 2026 | 1.212B |
| September 22, 2026 | 1.214B |
| September 21, 2026 | 1.191B |
| September 18, 2026 | 1.164B |
| September 17, 2026 | 1.145B |
| September 16, 2026 | 1.184B |
| September 15, 2026 | 1.170B |
| September 14, 2026 | 1.181B |
| September 11, 2026 | 1.169B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 99.23M |
| Orthofix Medical, Inc. | 433.51M |
| ResMed, Inc. | 32.90B |
| Rockwell Medical, Inc. | 15.86M |
| Microbot Medical, Inc. | -12.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.859M |
| Revenue (Quarterly) | 142.44M |
| Total Expenses (Quarterly) | 136.46M |
| EPS Diluted (Quarterly) | 0.0826 |
| Gross Profit Margin (Quarterly) | 67.45% |
| Profit Margin (Quarterly) | 4.82% |
| Earnings Yield | 8.16% |
| Operating Earnings Yield | 8.40% |
| Normalized Earnings Yield | 8.387 |